Cyclic nucleotide phosphodiesterase inhibitors, preparation...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 243/02 (2006.01) A61K 31/551 (2006.01) A61K 31/5513 (2006.01) A61P 25/00 (2006.01) A61P 25/24 (2006.01) C07D 243/14 (2006.01) C07D 243/24 (2006.01) C07D 401/04 (2006.01) C07D 403/04 (2006.01) C07D 405/04 (2006.01) C07D 405/10 (2006.01) C07D 409/04 (2006.01) C07D 409/10 (2006.01)

Patent

CA 2446696

The invention concerns novel benzodiazepinone derivatives and their uses in therapy particularly for treating pathologies involving the activity of a phosphodiesterase of cyclic nucleotides. The invention also concerns methods for preparing them and novel synthesis intermediates. The inventive compounds more particularly correspond to general formula (I).

L'invention concerne de nouveaux dérivés de type benzodiazépinones et leurs applications dans le domaine thérapeutique tout particulièrement pour le traitement de pathologies impliquant l'activité d'une phosphodiestérase de nucléotides cycliques. Elle concerne également des procédés pour leur préparation et de nouveaux intermédiaires de synthèse. Les composés de l'invention répondent plus particulièrement à la formule générale (I) :

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cyclic nucleotide phosphodiesterase inhibitors, preparation... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclic nucleotide phosphodiesterase inhibitors, preparation..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic nucleotide phosphodiesterase inhibitors, preparation... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1718508

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.